secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0001437749-25-021210
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia granted US Patent No. 12,311,127 for Helix catheter delivery system
-----------------------------------------------------------------------------

- Patent covers radial and trans-endocardial delivery catheter for biologic therapies.
- Protects helical needle-tipped catheter platform; cited as safest and most efficient approach.
- Helix system underlies CardiAMP Cell Therapy program for ischemic cardiomyopathies and refractory angina.
- CEO notes work toward separate approvals of the therapy and the delivery system.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774925021210/0001437749-25-021210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774925021210/bcda20250625_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-021210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer